Akebia Therapeutics

Akebia Therapeutics, Inc. is a pharmaceutical company focused on treating ischemia and improving vascular diseases. It is involved in the clinical development of compounds for the treatment of anemia and ischemia-related conditions. The company provides Omacor for hypertriglyceridemia and Actonel for osteoporosis. Its products include prolyl hydroxylase and phosphatase.